The leaders of CVS Well being Corp. have reined of their development plans for the corporate’s Medicare-focused Oak Avenue Well being clinics and booked a goodwill impairment cost of greater than $5.7 billion to account for his or her decrease monetary projections for the enterprise.
Rhode Island-based CVS purchased Oak Avenue in 2023 for almost $10 billion because it sought to scale its healthcare companies supply enterprise and join Oak Avenue’s value-based major care extra tightly to its Aetna insurance coverage group. Oak Avenue grew to greater than 230 areas by this time final yr and then-new CEO David Joyner stated that “the very fact is the mannequin works and it really works in underserved market particularly for the inhabitants that’s necessary to this enterprise.”
Nevertheless, in reporting CVS’ third-quarter outcomes Oct. 29, Joyner’s staff stated its broader healthcare supply group has confronted persistent challenges this yr that led it to make quite a lot of strategic adjustments. Amongst them is “the willpower (to) scale back the variety of new major care clinics it will open in 2026 and thereafter.”
CVS additionally will shut some present Oak Avenue clinics subsequent yr and booked an $83 million cost to its earnings throughout the third quarter to cowl prices it would incur due to these.
Chatting with analysts on a convention name, Joyner and Group President Prem Shah stated CVS’ healthcare supply division carried out as anticipated throughout the third quarter and that they continue to be dedicated to maintaining these companies within the firm’s fold.
“Worth-based care stays a vital part of our technique,” Joyner stated. “The explanations to imagine on this enterprise haven’t modified, however the market is evolving and we’re adapting our technique to get monetary efficiency again consistent with our expectations.”
Shah stated his staff is targeted totally on enhancing the phrases of a few of Oak Avenue’s contracts with different insurers in addition to rising the variety of Medicare members coming to every clinic. Together with investing in know-how and refining a medical mannequin centered on decreasing prices, Shah stated these initiatives are teeing up Oak Avenue to have a greater 2026 than 2025.
Unsurprisingly, the big goodwill impairment cost pushed CVS into the purple throughout the third quarter, when it posted a internet lack of almost $4 billion on complete revenues of roughly $103 billion. Adjusted working revenue, nonetheless, grew 36 % to $3.46 billion due to an excellent quarter from Aetna, which produced a $314 million adjusted working revenue and improved its medical advantages ratio to 92.8 % from greater than 95 % in final yr’s Q3.
CFO Brian Newman stated that that 92.8 determine was just a little noisy due to varied accounting changes—some going again to 2018 enterprise and a few associated to worsening expectations for people lined on Inexpensive Care Act exchanges—however pointed to constructive tendencies in Aetna’s particular person Medicare Benefit plans.
Shares of CVS (Ticker: CVS) fell about 2 % on the heels of the earnings report and convention name and gave up one other 5 % on Oct. 30. Over the previous six months, nonetheless, they’re nonetheless up about 15 %, which has grown the corporate’s market worth at about $97 billion.
